Latest News

Vertex Pharmaceuticals (NasdaqGS:VRTX) reported positive late-stage trial results for kidney disease drug povetacicept in IgA nephropathy. The drug met both primary and secondary endpoints, supporting plans to seek accelerated U.S. approval. Vertex expects to submit a Biologics License Application to the FDA by the end of March. For you as an investor, this news matters because it highlights how Vertex is expanding beyond its core focus in cystic fibrosis and acute pain. Povetacicept adds a...

If you are wondering whether E L Financial's share price still reflects its underlying worth, this article will walk through what the current numbers may be telling you about value. The stock has seen mixed recent returns, with a 1.9% decline over the last week, a 7.7% decline over the last month, a 4.3% decline year to date, but a 23.0% return over the past year and very large gains over three and five years of about 1.2x and 1.6x respectively. Recent coverage around E L Financial has...

Palo Alto Networks (PANW) has put partnerships at the center of its recent move in cybersecurity, announcing new collaborations with Nokia, U Mobile, Aeris, Celerway, and Siemens that target AI workloads, industrial automation, and private 5G security. See our latest analysis for Palo Alto Networks. These partnerships arrive as Palo Alto Networks’ recent share price has been under pressure, with a 90 day share price return of 13.02% and a year to date share price return of 7.69%, set against...

Zoom Communications (NasdaqGS:ZM) has expanded its enterprise AI platform with new workflow orchestration and agentic AI features across core products. The company also entered a partnership with PCI Pal to enable secure, compliant payments within Zoom Virtual Agent. These updates indicate a broader push to embed AI driven automation and payment capabilities directly into Zoom's communications ecosystem. Zoom Communications, trading at $76.38, sits at an interesting point for investors who...

If you are wondering whether Honeywell International's current share price lines up with its underlying worth, you are not alone, and that is exactly what this article is going to unpack. The stock recently closed at US$240.61, with a 1.3% decline over the last week, a 0.9% return over 30 days, and returns of 22.8% year to date, 25.1% over 1 year, 41.1% over 3 years, and 33.6% over 5 years. Recent news coverage has focused on Honeywell's positioning as a major industrial and technology...

Applied Digital (APLD) is back in the spotlight after launching a US$2.15b private offering of senior secured notes to fund its Polaris Forge 2 AI Factory campus, a move that sharpens focus on leverage and project execution. See our latest analysis for Applied Digital. Those funding headlines come after a choppy few months for the stock, with a 1-day share price return of 1.37% offering only a brief pause in a 30-day share price decline of 28.38%. At the same time, the 1-year total...

Webull (BULL) has caught investor attention after a period of weak share performance, with the stock down over the past month, past 3 months, year to date, and the past year. See our latest analysis for Webull. With the latest share price at $5.50, Webull’s recent momentum has been weak, with a 7 day share price return of a 7.72% decline and a 30 day share price return of a 16.41% decline, while the 1 year total shareholder return of a 53.05% loss indicates longer term holders have also felt...

Japan Exchange Group (TSE:8697) has kicked off a broad leadership transition, naming long time insider Yokoyama Ryusuke as Representative Executive Officer and Group COO, effective April 1, 2026, as veteran executive Iwanaga Moriyuki retires. See our latest analysis for Japan Exchange Group. The leadership reshuffle comes after a strong run in the shares, with a 30 day share price return of 13.92% and a year to date gain of 14.12%. The 3 year total shareholder return of 110.66% suggests...

Coeur Mining (CDE) has recently drawn investor attention as its shares trade near $23.35, alongside 1 day, week, month, past 3 months and 1 year total returns that highlight meaningful swings in sentiment. See our latest analysis for Coeur Mining. At the current share price of $23.35, Coeur Mining’s recent 30 day share price return of 8.91% and 90 day share price return of 46.21% sit alongside a very large 1 year total shareholder return of around 4x. This points to momentum that has been...

Mitsubishi (TSE:8058) is back in focus after Frontier Lithium announced a new non binding MoU with Panasonic Energy and Mitsubishi on potential lithium salts procurement linked to the PAK Lithium Project in Ontario. See our latest analysis for Mitsubishi. The lithium MoU lands at a time when Mitsubishi’s share price has been strong, with a 40.2% 3 month share price return and a 42.81% year to date share price return. The 1 year total shareholder return of 108.86% and 5 year total shareholder...

Datadog (NasdaqGS:DDOG) has launched its MCP Server for AI agent observability, now generally available for development teams. The company introduced capabilities to connect AI agents to governed, real-time production data inside existing workflows. Datadog also announced a new integration with Cohesity focused on automated incident recovery for production AI environments. The Cohesity partnership targets risks such as data loss, unwanted agent behavior, and regulatory compliance for AI...

Zevra Therapeutics (ZVRA) has wrapped up FY 2025 with Q4 total revenue of US$34.1 million and basic EPS of US$0.21, while trailing twelve month figures show total revenue of US$106.5 million and basic EPS of US$1.40. Over the past year, the company has seen total revenue move from US$23.6 million on a trailing basis in Q4 2024 to US$106.5 million by Q4 2025, alongside a shift from a trailing net loss of US$105.5 million to trailing net income of US$77.6 million. This sets the stage for a more...

Navitas Semiconductor (NVTS) has put product development in the spotlight, announcing a 250 kW solid state transformer demonstrator with EPFL and new GaN and SiC power solutions for AI data centers ahead of APEC 2026. See our latest analysis for Navitas Semiconductor. These product announcements come after a powerful run in total shareholder return, with a very large 1 year gain of 241.73%. However, recent 30 and 90 day share price returns of 2.03% and 4.82% declines suggest some of that...

If you are wondering whether Capital One Financial's share price really lines up with its fundamentals, this article will walk through what the current valuation signals are actually saying. The stock last closed at US$184.87, with returns of 13.3% over 1 year, 102.5% over 3 years and 57.5% over 5 years. More recent moves include a 4.6% decline over 7 days, a 17.0% decline over 30 days and a 25.4% decline year to date. Recent news flow around Capital One Financial has focused on its...

In recent days, BorgWarner has attracted renewed attention as UBS upgraded its rating to Neutral and other analysts adjusted their views amid the company’s transition toward electric-vehicle-focused parts. This wave of revised analyst opinions, including improved growth scores and higher consensus earnings estimates, highlights how expectations are evolving around BorgWarner’s shift in business mix and earnings profile. We’ll now examine how this fresh analyst optimism around BorgWarner’s...

Sato Foods (TSE:2923) has put up a punchy Q3 2026 scorecard, with revenue at about ¥19.97 billion and basic EPS of ¥407.15, set against a trailing twelve month EPS of ¥796.25 on revenue of roughly ¥50.63 billion as earnings growth over the past year reached 129.2%. The company has seen revenue move from around ¥44.65 billion with EPS of ¥434.60 in the trailing period to ¥50.63 billion with EPS of ¥796.25, while net profit margin stepped up from 3.9% to 7.9%, giving this latest quarter a more...

Why Enterprise Products Partners Is On Investors’ Radar Enterprise Products Partners (EPD) has drawn fresh attention after recent price moves, with the units last closing at $36.72. Investors are weighing that level against its income profile and long term return record. See our latest analysis for Enterprise Products Partners. Recent trading has been a bit mixed, with a 1 day share price return of a 1% decline and a 7 day share price return of a 1.8% decline. However, the 30 day and year to...

ASMPT (SEHK:522) has packed several updates into its latest announcement, combining first quarter 2026 revenue guidance, higher proposed dividends, and the planned divestment of NEXX into a single reference point for investors. See our latest analysis for ASMPT. Those updates are landing after a strong run in the shares, with ASMPT’s 90 day share price return of 45.27% and 1 year total shareholder return of 94.12% pointing to momentum building as investors reassess growth prospects and...

If you are wondering whether HP's current share price reflects its true worth, you are not alone. This article is built to help you weigh what the market is pricing in against what the fundamentals suggest. HP shares last closed at US$18.79, with returns of a 1.2% decline over 7 days, a 4.4% decline over 30 days, a 15.1% decline year to date, a 30.3% decline over 1 year and a 23.9% decline over 3 years. These moves will shape how many investors think about its risk and return profile...

Sanlorenzo (BIT:SL) is back in focus after its 2025 earnings call, where the yacht maker reported 3.2% revenue growth, a 16% rise in order intake to €130 million, and an 18.8% EBITDA margin. See our latest analysis for Sanlorenzo. At a share price of €30.55, Sanlorenzo has a 1-day share price return of 4.09% and a 7-day share price return of 1.16%, while the 30-day share price return of 5.56% contrasts with a 1-year total shareholder return of 11.07% and a 5-year total shareholder return of...

Guidance-driven spotlight on Simcere Pharmaceutical Group Simcere Pharmaceutical Group (SEHK:2096) has issued consolidated guidance for 2025, indicating expected revenue of RMB 7,700 million to RMB 7,800 million and profit attributable to equity shareholders of RMB 1,300 million to RMB 1,400 million. See our latest analysis for Simcere Pharmaceutical Group. The guidance update comes after a mixed share price run, with a 7 day share price return of 3.55% and a 90 day share price return decline...

If you are wondering whether Omnicom Group's current share price reflects its true value, you are not alone. This article is built to help you make sense of what you are paying for every US$1 invested. The stock last closed at US$80.98, with a 15.9% gain over the past 30 days, but a more muted 2.0% return over the past year and a small 0.4% decline year to date. Recent coverage has focused on Omnicom's position as a large global advertising and marketing group, including ongoing contracts...

Sihuan Pharmaceutical Holdings Group (SEHK:460) drew investor attention after China approved a new first-line indication for its Bireociclib Tablets in HR+/HER2- advanced breast cancer, expanding coverage across all treatment lines. See our latest analysis for Sihuan Pharmaceutical Holdings Group. At a share price of HK$1.49, the stock has seen a 6.43% 7 day share price return and a 16.41% 90 day share price return. The 1 year total shareholder return of 150.06% points to strong momentum,...

Centene (NYSE:CNC) highlighted worsening pressures in its Affordable Care Act marketplace business at the Barclays Healthcare Conference. The CEO pointed to a steeper than expected decline in ACA membership and continuing operational challenges. These comments indicate more acute risks for a key segment of Centene's operations than previously outlined. For investors watching NYSE:CNC, the fresh commentary comes after a challenging stretch for the stock. Centene closed at $36.40, with the...